CN Patent

CN106810512B — Idh2突变体抑制剂及其用途

Assigned to Jiangsu Provincial Insititute of Traditional Chinese Medicine · Expires 2019-09-10 · 7y expired

What this patent protects

本发明涉及式I的化合物及其药学上可接受的盐、溶剂和水合物，包含式I的化合物的药物组合物及其作为IDH突变体抑制剂用于制备预防或治疗IDH突变相关的疾病的药物的用途。

USPTO Abstract

本发明涉及式I的化合物及其药学上可接受的盐、溶剂和水合物，包含式I的化合物的药物组合物及其作为IDH突变体抑制剂用于制备预防或治疗IDH突变相关的疾病的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN106810512B
Jurisdiction
CN
Classification
—
Expires
2019-09-10
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Provincial Insititute of Traditional Chinese Medicine
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.